Boston Scientific’s Lotus Aortic Valve Has Promise in Study
This article is for subscribers only.
Boston Scientific Corp.’s Lotus device, inserted through a catheter into the heart to fix a damaged aortic valve, was safely implanted without any severe leakage in a study being conducted for European approval.
The findings presented at the EuroPCR meeting in Paris showed the Lotus device improved blood flow through the repaired aortic valve, without complications such as the need for by-pass surgery. One of the 60 patients developed moderate regurgitation around the valve, which has been tied to a higher risk of death, while 79 percent had little to no leakage. Almost 30 percent needed a pacemaker after treatment.